Your session is about to expire
← Back to Search
Diagnostic Device
Investigational Ultrasound Imaging for Liver Fat Quantification for Non-alcoholic Fatty Liver Disease
N/A
Waitlist Available
Led By Smita S Bailey, MD
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intra-procedural (1 day)
Awards & highlights
Study Summary
This study is evaluating whether a new ultrasound technique can help detect liver fat.
Eligible Conditions
- Non-alcoholic Fatty Liver Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ intra-procedural (1 day)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intra-procedural (1 day)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correlation of the liver fat percentage reported from MRI-PDFF with measurements of ultrasound biomarkers for liver fat.
Secondary outcome measures
Inter-operator variability in measurements of ultrasound biomarkers for liver fat
Ultrasound biomarker measurement failure rate
Trial Design
1Treatment groups
Experimental Treatment
Group I: Investigational Ultrasound Imaging for Liver Fat QuantificationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Investigational Liver Fat Quantification Software
2020
N/A
~100
Find a Location
Who is running the clinical trial?
Philips Clinical & Medical Affairs GlobalLead Sponsor
50 Previous Clinical Trials
16,544 Total Patients Enrolled
1 Trials studying Non-alcoholic Fatty Liver Disease
63 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Smita S Bailey, MDPrincipal InvestigatorPhoenix Children's Hospital
Share this study with friends
Copy Link
Messenger